Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.

Clinical trials sponsored by Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd., explained in plain language.

Trials to join now! 3 Not yet recruiting 1

New drug duo aims to fight tough liver cancer

Disease control Not yet recruiting

This study is testing whether a combination of two immunotherapy drugs, IBI310 and sintilimab, can help people with advanced liver cancer that cannot be removed by surgery. It will involve about 680 adults who have not yet received any drug treatment for their cancer. The main go…

Phase: PHASE2, PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC